Bias Capital Cancels $25M Investment in Parker Health Amid Fraud Concerns

What You Should Know: 

– Bias Capital, an angel syndicate, today announced the cancellation of its $25M Series A investment in healthcare technology company Parker Health.

– This decision follows alarming findings during the due diligence process, which raised serious concerns about potential fraudulent activities, including misleading financial disclosures and operational irregularities.

Due Diligence Uncovers Potential Financial Misconduct and Operational Irregularities

Parker Health, founded by Vincent Lopez, had ambitious plans to optimize the healthcare industry with its proprietary Health Management System™. However, Bias Capital’s investigation has uncovered significant issues regarding the company’s operational integrity and financial transparency including:

• Misleading financial disclosures: Evidence suggests that Parker Health may have misrepresented its financial performance.
• Operational irregularities: The investigation has revealed inconsistencies and irregularities in the company’s operations.
• Leadership implicated: Key leadership figures, including the CFO, former CTO, and CMO, are implicated in the potential misconduct.

Bias Capital is committed to cooperating with relevant authorities to conduct a thorough investigation into the potential misconduct at Parker Health. The company will provide updates on the investigation as new information becomes available.

“Our responsibility as investors is clear: we will not support a company that compromises transparency and ethical standards,” stated Maximillian Naza, General Partner at Bias Capital. “We urge all investors to assess their portfolios critically and remain vigilant. If you have concerns about Parker Health, please reach out to us or seek legal counsel. Together, we can foster a culture of accountability in our industry.”